Switch to:
More From Other Websites
BioTime, Inc. is trading above its 50 day moving average : BTX-US : September 21, 2017 Sep 21 2017
BioTime to Present at the Cantor Fitzgerald Global Healthcare Conference Sep 20 2017
BioTime to Present at the Ladenburg Thalmann 2017 Healthcare Conference Sep 20 2017
BioTime Awarded Grant from the NIH Sep 18 2017
Two Key BioTime Patents Providing Protection to OpRegen® Remain Upheld Sep 14 2017
ETFs with exposure to BioTime, Inc. : September 12, 2017 Sep 11 2017
BioTime, Inc. :BTX-US: Earnings Analysis: Q2, 2017 By the Numbers : September 9, 2017 Sep 08 2017
BioTime to Present at the Rodman & Renshaw Annual Global Investment Conference Sep 08 2017
BioTime to Present at the LD Micro San Francisco Summit Sep 05 2017
BioTime, Inc. breached its 50 day moving average in a Bullish Manner : BTX-US : September 1, 2017 Sep 01 2017
BioTime to Present Data at the Military Health System Research Symposium Aug 28 2017
AgeX Therapeutics Closes $10 Million Capital Raise Aug 17 2017
BioTime Announces $2 Million Grant for Further Development of OpRegen® for Dry-AMD Aug 14 2017
Edited Transcript of BTX earnings conference call or presentation 2-Aug-17 8:30pm GMT Aug 11 2017
AgeX Therapeutics CEO Michael D. West, Ph.D. to Deliver Keynote Address on Biotechnology and Aging... Aug 09 2017
BioTime reports 2Q loss Aug 04 2017
BioTime Reports Second Quarter Results and Recent Corporate Accomplishments Aug 02 2017
Investor Network: BIOTIME INC to Host Earnings Call Aug 02 2017
AgeX Therapeutics Obtains $10 Million in Capital and Commences Operations Aug 02 2017
BioTime, Inc. – Value Analysis (NYSE MKT:BTX) : July 31, 2017 Jul 31 2017


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}
FEEDBACK